Header Logo

Connection

CRAIG LOGSDON to Cell Line, Tumor

Back to Details
This is a "connection" page, showing publications CRAIG LOGSDON has written about Cell Line, Tumor.
CRAIG LOGSDON
Connection Strength
0.841
Cell Line, Tumor
  1. RAGE maintains high levels of NF?B and oncogenic Kras activity in pancreatic cancer. Biochem Biophys Res Commun. 2017 11 04; 493(1):592-597.
    View in: PubMed
    Score: 0.052
  2. TM4SF1 Regulates Pancreatic Cancer Migration and Invasion In Vitro and In Vivo. Cell Physiol Biochem. 2016; 39(2):740-50.
    View in: PubMed
    Score: 0.048
  3. TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo. PLoS One. 2015; 10(12):e0144969.
    View in: PubMed
    Score: 0.046
  4. Cell surface lactate receptor GPR81 is crucial for cancer cell survival. Cancer Res. 2014 Sep 15; 74(18):5301-10.
    View in: PubMed
    Score: 0.042
  5. Targeting pancreatic ductal adenocarcinoma acidic microenvironment. Sci Rep. 2014 Mar 19; 4:4410.
    View in: PubMed
    Score: 0.041
  6. Oncogenic K-Ras requires activation for enhanced activity. Oncogene. 2014 Jan 23; 33(4):532-5.
    View in: PubMed
    Score: 0.038
  7. Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy. Mol Cancer Ther. 2013 May; 12(5):654-62.
    View in: PubMed
    Score: 0.038
  8. S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis. Clin Cancer Res. 2012 Aug 15; 18(16):4356-64.
    View in: PubMed
    Score: 0.036
  9. Detection of pancreatic cancer tumours and precursor lesions by cathepsin E activity in mouse models. Gut. 2012 Sep; 61(9):1315-22.
    View in: PubMed
    Score: 0.035
  10. Trefoil factor 1 stimulates both pancreatic cancer and stellate cells and increases metastasis. Pancreas. 2011 Aug; 40(6):815-22.
    View in: PubMed
    Score: 0.034
  11. The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment. PLoS One. 2009 Oct 22; 4(10):e7502.
    View in: PubMed
    Score: 0.030
  12. Ras activity levels control the development of pancreatic diseases. Gastroenterology. 2009 Sep; 137(3):1072-82, 1082.e1-6.
    View in: PubMed
    Score: 0.029
  13. Nuclear factor-kappaB p65/relA silencing induces apoptosis and increases gemcitabine effectiveness in a subset of pancreatic cancer cells. Clin Cancer Res. 2008 Dec 15; 14(24):8143-51.
    View in: PubMed
    Score: 0.029
  14. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008 Feb 01; 68(3):918-26.
    View in: PubMed
    Score: 0.027
  15. Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR. Cancer Res. 2007 Mar 15; 67(6):2666-75.
    View in: PubMed
    Score: 0.025
  16. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst. 2006 Dec 20; 98(24):1806-18.
    View in: PubMed
    Score: 0.025
  17. S100P promotes pancreatic cancer growth, survival, and invasion. Clin Cancer Res. 2005 Aug 01; 11(15):5356-64.
    View in: PubMed
    Score: 0.023
  18. Oligonucleotide-directed microarray gene profiling of pancreatic adenocarcinoma. Methods Mol Med. 2005; 103:175-87.
    View in: PubMed
    Score: 0.022
  19. Hematopoietic progenitor kinase 1 down-regulates the oncogenic receptor tyrosine kinase AXL in pancreatic cancer. J Biol Chem. 2020 02 21; 295(8):2348-2358.
    View in: PubMed
    Score: 0.015
  20. DIRAS3 (ARHI) Blocks RAS/MAPK Signaling by Binding Directly to RAS and Disrupting RAS Clusters. Cell Rep. 2019 12 10; 29(11):3448-3459.e6.
    View in: PubMed
    Score: 0.015
  21. Suppression of stromal-derived Dickkopf-3 (DKK3) inhibits tumor progression and prolongs survival in pancreatic ductal adenocarcinoma. Sci Transl Med. 2018 10 24; 10(464).
    View in: PubMed
    Score: 0.014
  22. Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via?Integrin Signaling. Gastroenterology. 2018 04; 154(5):1524-1537.e6.
    View in: PubMed
    Score: 0.013
  23. New Blocking Antibodies against Novel AGR2-C4.4A Pathway Reduce Growth and Metastasis of Pancreatic Tumors and Increase Survival in Mice. Mol Cancer Ther. 2015 Apr; 14(4):941-51.
    View in: PubMed
    Score: 0.011
  24. Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma. Mol Cancer Ther. 2014 Nov; 13(11):2583-94.
    View in: PubMed
    Score: 0.011
  25. Dynamic mast cell-stromal cell interactions promote growth of pancreatic cancer. Cancer Res. 2013 Jul 01; 73(13):3927-37.
    View in: PubMed
    Score: 0.010
  26. Pancreatic cancer-associated Cathepsin E as a drug activator. J Control Release. 2013 May 10; 167(3):221-7.
    View in: PubMed
    Score: 0.010
  27. Adrenomedullin is up-regulated in patients with pancreatic cancer and causes insulin resistance in ? cells and mice. Gastroenterology. 2012 Dec; 143(6):1510-1517.e1.
    View in: PubMed
    Score: 0.009
  28. Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling. PLoS One. 2012; 7(8):e42699.
    View in: PubMed
    Score: 0.009
  29. Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer. Mol Cancer Res. 2012 Sep; 10(9):1147-57.
    View in: PubMed
    Score: 0.009
  30. Met receptor tyrosine kinase signaling induces secretion of the angiogenic chemokine interleukin-8/CXCL8 in pancreatic cancer. PLoS One. 2012; 7(7):e40420.
    View in: PubMed
    Score: 0.009
  31. A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis. Cancer Res. 2012 Feb 01; 72(3):655-65.
    View in: PubMed
    Score: 0.009
  32. Molecular imaging of Cathepsin E-positive tumors in mice using a novel protease-activatable fluorescent probe. Mol Biosyst. 2011 Dec; 7(12):3207-3213.
    View in: PubMed
    Score: 0.009
  33. Overexpression of receptor tyrosine kinase Axl promotes tumor cell invasion and survival in pancreatic ductal adenocarcinoma. Cancer. 2011 Feb 15; 117(4):734-43.
    View in: PubMed
    Score: 0.008
  34. ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB. Clin Cancer Res. 2010 Mar 01; 16(5):1423-30.
    View in: PubMed
    Score: 0.008
  35. Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancer. Cancer Res. 2009 Jul 15; 69(14):5820-8.
    View in: PubMed
    Score: 0.007
  36. Proteasome-mediated degradation and functions of hematopoietic progenitor kinase 1 in pancreatic cancer. Cancer Res. 2009 Feb 01; 69(3):1063-70.
    View in: PubMed
    Score: 0.007
  37. Neutrophil gelatinase-associated lipocalin: a novel suppressor of invasion and angiogenesis in pancreatic cancer. Cancer Res. 2008 Aug 01; 68(15):6100-8.
    View in: PubMed
    Score: 0.007
  38. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci U S A. 2007 Nov 20; 104(47):18636-41.
    View in: PubMed
    Score: 0.007
  39. RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis Colon Rectum. 2007 Aug; 50(8):1230-40.
    View in: PubMed
    Score: 0.006
  40. Dual targeting of endothelial cells and pericytes in antivascular therapy for ovarian carcinoma. Clin Cancer Res. 2007 Jul 15; 13(14):4209-17.
    View in: PubMed
    Score: 0.006
  41. Sphingosine-1-phosphate induces early response gene expression in C6 glioma cells. Brain Res Mol Brain Res. 2005 Feb 18; 133(2):325-8.
    View in: PubMed
    Score: 0.005
  42. The molecular basis of pancreatic fibrosis: common stromal gene expression in chronic pancreatitis and pancreatic adenocarcinoma. Pancreas. 2004 Nov; 29(4):254-63.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.